Dong Xu Qiu
Founder at CANSINO BIOLOGICS INC.
Profile
Dong Xu Qiu founded CanSino Biologics, Inc. He is on the board of CanSino Biologics, Inc. and Senior Advisor at ChinaBio LLC. Dr. Qiu received a doctorate from Peking University, an MBA from the University of Western Ontario, an undergraduate degree from Shenyang Pharmaceutical University, a doctorate from Universität Konstanz and a doctorate from the University of Montréal.
Dong Xu Qiu active positions
Companies | Position | Start |
---|---|---|
CANSINO BIOLOGICS INC. | Founder | 2009-01-12 |
Suzhou GenePharma Co., Ltd.
Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Suzhou GenePharma Co.,Ltd. engages in the manufacture of biotechnology products. Its products cover chemically-synthetic RNA monomer, RNA oligo synthesis, and the relevant modifiers, labeling, and fluorescein reagents. The company was founded on August 27, 2007 and is headquartered in Shanghai, China. | Director/Board Member | - |
Former positions of Dong Xu Qiu
Companies | Position | End |
---|---|---|
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2011-03-31 |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | 2001-12-31 |
Training of Dong Xu Qiu
Peking University | Doctorate Degree |
University of Western Ontario | Masters Business Admin |
University of Montréal | Doctorate Degree |
Universität Konstanz | Doctorate Degree |
Shenyang Pharmaceutical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CANSINO BIOLOGICS INC. | Health Technology |
Health Technology |
Private companies | 2 |
---|---|
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Finance |
- Stock Market
- Insiders
- Dong Xu Qiu